Search Results - "Baliga, Uday K."

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Hematopoietic stem cell‐derived functional osteoblasts exhibit therapeutic efficacy in a murine model of osteogenesis imperfecta by Kang, In‐Hong, Baliga, Uday K., Wu, Yongren, Mehrotra, Shikhar, Yao, Hai, LaRue, Amanda C., Mehrotra, Meenal

    Published in Stem cells (Dayton, Ohio) (01-11-2021)
    “…Currently, there is no cure for osteogenesis imperfecta (OI)—a debilitating pediatric skeletal dysplasia. Herein we show that hematopoietic stem cell (HSC)…”
    Get full text
    Journal Article
  2. 2

    Quantitative increase in T regulatory cells enhances bone remodeling in osteogenesis imperfecta by Kang, In-Hong, Baliga, Uday K., Chatterjee, Shilpak, Chakraborty, Paramita, Choi, Seungho, Buchweitz, Nathan, Li, Hong, Wu, Yongren, Yao, Hai, Mehrotra, Shikhar, Mehrotra, Meenal

    Published in iScience (16-09-2022)
    “…Osteogenesis imperfecta (OI) is characterized by repeated bone fractures. Recent studies have shown that T lymphocytes and regulatory T cells (Tregs) regulate…”
    Get full text
    Journal Article
  3. 3

    Pulmonary gene delivery—Realities and possibilities by Baliga, Uday K, Dean, David A

    “…Delivery of genetic material to tissues in vivo is an important technique used in research settings and is the foundation upon which clinical gene therapy is…”
    Get full text
    Journal Article
  4. 4

    Impact of Peptide Sequence on Functional siRNA Delivery and Gene Knockdown with Cyclic Amphipathic Peptide Delivery Agents by Jagrosse, Melissa L, Baliga, Uday K, Jones, Christopher W, Russell, Jade J, García, Claudia I, Najar, Rauf Ahmad, Rahman, Arshad, Dean, David A, Nilsson, Bradley L

    Published in Molecular pharmaceutics (04-12-2023)
    “…Short-interfering RNA (siRNA) oligonucleotide therapeutics that modify gene expression by accessing RNA-interference (RNAi) pathways have great promise for the…”
    Get full text
    Journal Article